Prostate Cancer

The removal of the prostate gland, a procedure known as a prostatectomy, typically results in the absence of semen during ejaculation. This is because the prostate produces a significant portion of the seminal fluid that makes up semen. Without the prostate, the remaining structures, such as the seminal vesicles, may still produce some fluid, but it will not be enough to constitute typical ejaculation. As a result, men may experience dry orgasms post-surgery.

Yes, it is possible to have sex after prostate and bladder removal, but experiences may vary. Many men may face challenges such as erectile dysfunction or changes in sexual function. However, with appropriate medical guidance, including the use of medications or devices, many can still achieve satisfying sexual experiences. It's important to discuss any concerns with a healthcare provider for tailored advice and support.

Arm and back pain can be associated with various conditions, including prostate cancer, particularly if the cancer has metastasized to the bones. However, these symptoms are not definitive indicators of cancer spread, as they can also result from other issues such as muscle strain or degenerative diseases. If someone with prostate cancer experiences new or worsening pain, it's important to consult a healthcare professional for proper evaluation and diagnosis.

Lupron (leuprolide) can lead to bone loss, particularly with long-term use, typically after 6 months or more of treatment. The risk of osteoporosis and bone density reduction increases the longer the therapy continues, especially if not managed with other medications or lifestyle changes. Regular monitoring and potential supplementation with calcium and vitamin D may help mitigate these effects. Always consult with a healthcare provider for personalized advice and monitoring.

Signs of prostate cancer that should prompt males of all ages to seek healthcare include difficulty urinating, a weak or interrupted urine flow, blood in urine or semen, painful ejaculation, and persistent pain in the lower back, hips, or pelvis. Other symptoms may include unexplained weight loss and fatigue. Early detection is crucial, so any concerning symptoms should be discussed with a healthcare professional promptly. Regular screenings and discussions about prostate health are also recommended, especially for those at higher risk.

Adenofibromyomatous hyperplasia of the prostate refers to a benign enlargement of the prostate gland characterized by an increase in both glandular (adenomatous) and fibromuscular (fibromyomatous) tissues. This condition is often associated with aging and can lead to urinary symptoms due to compression of the urethra. It is distinct from prostate cancer and is considered a non-cancerous proliferation of prostate tissue. Management typically involves monitoring or treatment of associated symptoms.

The five stages of a disease typically include:

1. Incubation Period: The time between exposure to the pathogen and the onset of symptoms.
2. Prodromal Stage: Initial, non-specific symptoms appear, signaling the onset of the disease.
3. Acute Stage: The disease reaches its peak severity, with pronounced symptoms and effects.
4. Recovery Stage: Symptoms begin to subside as the body fights off the infection and starts to heal.
5. Convalescence: The body returns to its pre-disease state, although full recovery may take time.

The normal prostate size varies with age. In young men (ages 20-30), the prostate typically measures about 20-25 grams. By middle age (around 40-60 years), it may increase to 30-40 grams, and in older men (over 60), it can grow to 40-60 grams or more due to benign prostatic hyperplasia (BPH). It's important to note that individual variations exist, and prostate size alone isn't a definitive indicator of health.

Yes, the average weight of a healthy prostate gland in adult men is typically around 20 to 30 grams, although it can vary. Weights can be influenced by factors such as age and individual differences. A prostate weight of 47 grams would be considered enlarged, which may indicate conditions such as benign prostatic hyperplasia or other prostate issues. Regular medical check-ups are important for monitoring prostate health.

Ngu, or "nug," is often a colloquial term that may refer to various substances or behaviors, but if you're referring to a specific drug or practice, please clarify. In general, certain substances or lifestyle factors can impact prostate health, potentially leading to issues like inflammation or prostate enlargement. However, without specific context, it's challenging to provide a definitive answer. Always consult a healthcare professional for personalized advice regarding prostate health.

The term "proteste cancer" does not appear to refer to any widely recognized concept or phenomenon in medical literature or activism. It might be a typographical error or a misunderstanding of related terms, such as "prostate cancer" or "protest against cancer." Prostate cancer is a common form of cancer affecting the prostate gland in men, often involving advocacy and awareness campaigns to promote research and support for those affected. If you meant something else, please provide more context for clarification.

A large prostate, or benign prostatic hyperplasia (BPH), is primarily caused by hormonal changes as men age, particularly the increase in estrogen and the influence of dihydrotestosterone (DHT) on prostate tissue. Other factors may include genetics and lifestyle choices such as diet and exercise. While the exact cause is not fully understood, these factors contribute to the growth of prostate cells, leading to an enlarged prostate.

Yes, PSA (prostate-specific antigen) levels can be zero, especially in individuals who do not have prostate cancer or any prostate-related conditions. A PSA level of zero is often seen in younger men and those who have undergone a prostatectomy (surgical removal of the prostate). However, it's important to note that PSA levels can vary and are not the sole indicator of prostate health; other factors and tests should be considered for a comprehensive assessment.

The code for cystoscopy is typically 52000, which is used for diagnostic cystoscopy. For electrosurgical transurethral resection of the prostate (TURP), the commonly used code is 52450. These codes may vary slightly based on specific circumstances or additional procedures performed, so it's important to consult the latest coding guidelines or a medical coding professional for accuracy.

Another name for the prostate is the "prostate gland." It is a small gland located below the bladder in males and plays a crucial role in the reproductive system by producing seminal fluid that nourishes and transports sperm.

The standard dosage for adjuvant radiation therapy for prostate cancer typically ranges from 60 to 70 gray (Gy), delivered in daily fractions of 1.8 to 2.0 Gy over several weeks. The specific dosage and treatment schedule may vary based on individual patient factors, including disease characteristics and prior treatments. It's essential for patients to discuss their specific case with their oncologist to determine the most appropriate plan.

A Public Service Announcement (PSA) should contain a clear and concise message that addresses a specific issue or concern, aiming to inform or educate the public. It should include relevant facts or statistics to support the message, and a call to action encouraging viewers to take specific steps or change behaviors. Additionally, a PSA should be engaging and memorable, using visuals or storytelling to capture attention and resonate with the audience.

Concretions are typically formed in sedimentary rocks and occur when minerals precipitate from water, often in the presence of organic materials or other particles. They can develop in various environments, including riverbeds, lakes, and ocean floors, where sediment accumulates. Over time, these minerals crystallize around a nucleus, leading to the formation of rounded, compact masses. Common minerals involved include calcite, silica, and iron oxides.

Anabolic steroids, including testosterone, can influence prostate cancer by promoting the growth of prostate cells. Elevated testosterone levels may stimulate the proliferation of existing cancerous cells, potentially increasing the risk of developing prostate cancer or exacerbating existing tumors. However, the relationship is complex, as testosterone can also have varying effects depending on individual patient factors and the specific characteristics of the cancer. Due to these potential risks, careful monitoring and management are essential for individuals using anabolic steroids, particularly those with a history of prostate issues.

Yes, babies do have a prostate, although it is not fully developed at birth. The prostate gland starts to form during fetal development and continues to grow and mature during puberty. In newborns, it is small and not functional, but it plays a role in male reproductive health later in life.

Prostate cancer can affect the urinary system by obstructing the urethra, leading to difficulties in urination, such as increased frequency, urgency, and weak urine flow. As the tumor grows, it may press against the bladder or urethra, causing pain and discomfort. Additionally, treatments for prostate cancer, such as surgery or radiation, can further impact urinary function, potentially resulting in incontinence or other urinary complications. Regular monitoring and management of urinary symptoms are important for patients with prostate cancer.

Yes, a PSA level of 78 ng/mL is considered very high. Normal PSA levels are typically below 4 ng/mL, and elevated levels can indicate prostate issues, including benign conditions or prostate cancer. It's important for individuals with such high levels to consult a healthcare professional for further evaluation and potential diagnostic procedures.

A high prostate-specific antigen (PSA) score may indicate an increased risk of prostate issues, including benign conditions like prostatitis or an enlarged prostate, as well as prostate cancer. However, elevated PSA levels are not definitive for cancer, as they can result from various factors such as age, infection, or recent medical procedures. Further diagnostic evaluation, including biopsies or imaging, is often necessary to determine the underlying cause of a high PSA score. It's important for individuals with elevated PSA levels to discuss their results with a healthcare provider for appropriate interpretation and next steps.

The prostate-specific antigen (PSA) level can vary based on individual health and other factors, but generally, a normal PSA level for a man around age 60 is often considered to be below 4.0 ng/mL. However, levels can be higher due to various conditions, including benign prostatic hyperplasia or prostatitis, not just prostate cancer. It's important for individuals to discuss their specific PSA results with their healthcare provider for appropriate interpretation and recommendations. Regular screening and monitoring may be advised based on personal and family health history.

The decision to undergo prostate surgery at age 85 should be made on an individual basis, considering the patient's overall health, life expectancy, and quality of life. Potential benefits must be weighed against the risks of surgery, such as complications and recovery challenges. Consulting with a healthcare provider who specializes in geriatric care and prostate issues can help determine the most appropriate course of action. In many cases, less invasive treatments or active surveillance may be recommended instead.